Drug Profile
Research programme: microsomal prostaglandin E synthase-1 inhibitors - Angelini
Alternative Names: AF3485; Eicosanoid inhibitors; Eicosanoid modulatorsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Angelini Group
- Class
- Mechanism of Action Prostaglandin-E synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Inflammatory pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Italy
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammatory-pain in Italy
- 25 Jul 2011 Programme is still in preclinical development for Inflammatory pain in Italy